Revelation Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REVB and other ETFs, options, and stocks.About REVB
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity.
CEOJames M. Rolke
CEOJames M. Rolke
Employees9
Employees9
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2019
Founded2019
Employees9
Employees9
REVB Key Statistics
Market cap3.01M
Market cap3.01M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume31.94K
Average volume31.94K
High today$3.30
High today$3.30
Low today$3.00
Low today$3.00
Open price$3.24
Open price$3.24
Volume17.17K
Volume17.17K
52 Week high$60.80
52 Week high$60.80
52 Week low$2.36
52 Week low$2.36
People also own
Based on the portfolios of people who own REVB. This list is generated using Robinhood data, and it’s not a recommendation.